BSX vs HROW · P/E 20, rev $10.65B vs rev $114.9M
Boston Scientific Corp (BSX) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HROW currently screens at market cap $1.28B.
Not investment advice. Open the BSX and HROW stock pages for the full models.
Not investment advice.